Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Gritstone bio Inc.

    NASDAQ: GRTS · Real-Time Price · USD
    0.03
    -0.02 (-36.44%)
    At close: Oct 21, 2024, 8:00 PM
    -36.44%
    Bid n/a
    Market Cap 3.8M
    Revenue (ttm) 1.7M
    Net Income (ttm) -133.03M
    EPS (ttm) -1.09
    PE Ratio (ttm) -0.029541284403669724
    Forward PE n/a
    Analyst Hold
    Ask n/a
    Volume 55,246,959
    Avg. Volume (20D) 17,011,671
    Open 0.04
    Previous Close 0.05
    Day's Range 0.03 - 0.04
    52-Week Range 0.03 - 3.17
    Beta 0.50

    About GRTS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol GRTS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for GRTS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    7 months ago
    Gritstone Bio shares are trading lower after the c... Unlock content with Pro Subscription
    7 months ago
    Gritstone Bio shares are trading lower after JMP Securities downgraded the stock from Market Outperform to Market Perform.
    news image

    7 months ago · businesswire.com

    Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure

    EMERYVILLE, Calif.--(BUSINESS WIRE)--Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a clinical-stage biotechnology company working to develop the world's most potent vaccines, toda...

    news image

    7 months ago · benzinga.com

    Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors'

    On Monday, Gritstone Bio Inc. GRTS revealed interim Phase 2 data from the ongoing Phase 2 study evaluating GRANITE, its individualized neoantigen-targeting immunotherapy, in frontline microsatellite-s...

    news image

    9 months ago · zacks.com

    Gritstone bio Inc. (GRTS) Reports Q2 Loss, Misses Revenue Estimates

    Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.31 per share a year ago.

    news image

    9 months ago · businesswire.com

    GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm

    LOS ANGELES--(BUSINESS WIRE)--GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm.

    news image

    10 months ago · businesswire.com

    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Gritstone bio, Inc. (GRTS)

    LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 6, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of inves...

    news image

    10 months ago · businesswire.com

    Gritstone bio, Inc. Stockholders With Significant Losses Should Contact Robbins LLP for Information About the GRTS Class Action Lawsuit

    SAN DIEGO--(BUSINESS WIRE)---- $GRTS #GRTS--Robbins LLP is Investigating Allegations that Gritstone bio, Inc. (GRTS) Misled Investors Regarding the Initiation of its Phase 2b CORAL Study.

    news image

    10 months ago · businesswire.com

    GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    LOS ANGELES--(BUSINESS WIRE)--GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm.

    news image

    10 months ago · businesswire.com

    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Gritstone bio, Inc. (GRTS)

    BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming August 6, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who pu...

    news image

    10 months ago · businesswire.com

    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Gritstone bio, Inc. (GRTS) Investors

    LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purch...

    news image

    10 months ago · businesswire.com

    GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

    NEW YORK--(BUSINESS WIRE)---- $GRTS #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been f...

    Add to Watchlist